title: Patient safety issues in CKD: core curriculum 2015.
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Baltimore, MD.
authors.forename: Lee-Ann
authors.initials: LA
authors.lastname: Wagner
authors.affiliation: Division of Pharmacy Services, University of Maryland Medical Center, Baltimore, MD.
authors.forename: Asha L
authors.initials: AL
authors.lastname: Tata
authors.affiliation: Department of Medicine, University of Maryland School of Medicine, Baltimore, MD. Electronic address: jfink@medicine.umaryland.edu.
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Fink
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced; D000368:Aged; D000700:Analgesics / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D000925:Anticoagulants / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D003287:Contrast Media / Q000009:adverse effects; D003928:Diabetic Nephropathies / Q000188:drug therapy; D004347:Drug Interactions; D005682:Gadolinium / Q000009:adverse effects; D005919:Glomerular Filtration Rate; D006397:Hematinics / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced / Q000150:complications / Q000503:physiopathology; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D017613:Iodine Compounds / Q000009:adverse effects; D007668:Kidney / Q000503:physiopathology; D008508:Medication Errors; D008657:Metabolic Clearance Rate; D059408:Pain Management; D061214:Patient Safety; D010599:Pharmacokinetics; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D051436:Renal Insufficiency, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D012084:Renin-Angiotensin System / Q000187:drug effects / Q000502:physiology
chemical_list: D000700:Analgesics; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D003287:Contrast Media; D006397:Hematinics; D007004:Hypoglycemic Agents; D007328:Insulin; D017613:Iodine Compounds; D010975:Platelet Aggregation Inhibitors; D005682:Gadolinium